Compounds > buthionine sulfoximine
Page last updated: 2024-08-22

buthionine sulfoximine and imatinib mesylate

buthionine sulfoximine has been researched along with imatinib mesylate in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (66.67)29.6817
2010's1 (33.33)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Härtel, N; Hehlmann, R; Hochhaus, A; Konig, H; La Rosée, P; Lorentz, C; Melo, JV; Schatz, M; Schultheis, B1
Ferreira, AC; Klumb, CE; Kwee, JK; Luque, DG; Maia, RC; Silva, KL; Vasconcelos, FC1
Augustyniak, D; Bartkowiak, A; Goffeau, A; Gonchar, M; Ko, YH; Lis, P; Majkowska-Skrobek, G; Pedersen, PL; Ułaszewski, S1

Other Studies

3 other study(ies) available for buthionine sulfoximine and imatinib mesylate

ArticleYear
Enhanced Bcr-Abl-specific antileukemic activity of arsenic trioxide (Trisenox) through glutathione-depletion in imatinib-resistant cells.
    Haematologica, 2007, Volume: 92, Issue:6

    Topics: Arsenic Trioxide; Arsenicals; Benzamides; Buthionine Sulfoximine; Cell Line, Tumor; Drug Resistance, Neoplasm; Drug Synergism; Drug Therapy, Combination; Fusion Proteins, bcr-abl; Glutathione; Humans; Imatinib Mesylate; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Oxides; Piperazines; Pyrimidines

2007
Modulation of reactive oxygen species by antioxidants in chronic myeloid leukemia cells enhances imatinib sensitivity through survivin downregulation.
    Anti-cancer drugs, 2008, Volume: 19, Issue:10

    Topics: Amitrole; Antineoplastic Agents; Antioxidants; Benzamides; Buthionine Sulfoximine; Dose-Response Relationship, Drug; HL-60 Cells; Humans; Imatinib Mesylate; Inhibitor of Apoptosis Proteins; K562 Cells; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Microtubule-Associated Proteins; Neoplasm Proteins; Piperazines; Pyrimidines; Reactive Oxygen Species; Survivin

2008
Killing multiple myeloma cells with the small molecule 3-bromopyruvate: implications for therapy.
    Anti-cancer drugs, 2014, Volume: 25, Issue:6

    Topics: Adenosine Triphosphate; Antineoplastic Agents; Benzamides; Buthionine Sulfoximine; Cell Survival; Glutathione; Humans; Imatinib Mesylate; Inhibitory Concentration 50; Lactic Acid; Monocarboxylic Acid Transporters; Multiple Myeloma; Piperazines; Pyrimidines; Pyruvates; Symporters; Tumor Cells, Cultured

2014